EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development and evaluation of the automated multipurpose molecular testing system PCRpack for high-throughput SARS-CoV-2 testing

Yasufumi Matsumura iD, Tomofumi Nakazaki, Kanako Kitamori, Eiki Kure, Koh Shinohara, Yasuhiro Tsuchido, Satomi Yukawa, Taro Noguchi, Masaki Yamamoto, Miki Nagao

Microbiology Spectrum · 2023

DOI: 10.1128/spectrum.02716-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Yasufumi Matsumura und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine , Kyoto, Japan. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: COVID-19 Private Fund (to the Shinya Yamanaka laboratory, CiRA, Kytoo, Japan), Nippon Control System, Beckman Coulter.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increasing the reliable testing capacity for SARS-CoV-2 is important for the diagnosis and control of COVID-19. We developed an automated, customizable, easy-to-implement molecular testing system, named PCRpack, for the high-throughput testing of SARS-CoV-2. PCRpack includes a liquid handling instrument enclosed in a negative-pressure clean booth (Biomek i5), a laboratory information management system (SimpPCR), other equipment, and documents that are needed for testing operation. An in vitro diagnostic assay was employed to detect SARS-CoV-2. System performance was evaluated based on liquid handling accuracy and precision, analytical sensitivity, clinical diagnostic performance, and testing capacity per day. Clinical diagnostic performance was determined against the reference extraction-based reverse transcription-PCR assay using 3,965 upper respiratory samples. Analytical sensitivity analysis showed a lower limit of detection of 1,000 genome copies/mL of sample. The accuracy and precision of sample or reagent dispensing in PCRpack ranged from −2.24% to 0.73% and 0.83% to 4.52%, respectively. In the evaluation of clinical samples, PCRpack showed a positive percent agreement of 96.6% and a negative percent agreement of 100% compared with the reference assay. The average turnaround times per 94 samples and the maximum numbers of tests within an 8-hour shift of one operator were 2 hours and 28 minutes vs 2 hours and 1 minute and 564 vs 376 samples for PCRpack and the manual method, respectively. The developed PCRpack system shows high liquid handling and clinical diagnostic performance and is a promising testing system for increasing the SARS-CoV-2 testing capacity and testing future emerging pathogens. IMPORTANCE Accurate and fast molecular testing is important for the diagnosis and control of COVID-19. During patient surges in the COVID-19 pandemic, laboratories were challenged by a higher demand for molecular testing under skilled staff shortages. We developed an automated multipurpose molecular testing system, named PCRpack, for the rapid, high-throughput testing of infectious pathogens, including SARS-CoV-2. The system is provided in an all-in-one package, including a liquid handling instrument, a laboratory information management system, and other materials needed for testing operation; is highly customizable; and is easily implemented. PCRpack showed robust liquid handling performance, high clinical diagnostic performance, a shorter turn-around time with minimal hands-on time, and a high testing capacity. These features contribute to the rapid implementation of the high-performance and high-throughput molecular testing environment at any phase of the pandemic caused by SARS-CoV-2 or future emerging pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansCOVID-19 TestingClinical Laboratory TechniquesPandemicsMolecular Diagnostic Techniques

Stichwörter der Autor:innen

COVID-19RT-PCRSARS-CoV-2automationliquid handling instrument

Autor:innen und Institutionen

  • Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine , Kyoto, Japan.
  • Beckman Coulter , Tokyo, Japan.
  • Nippon Control System , Yokohama, Japan.
  • Faculty of Pharmacy, Kyoto Pharmaceutical University , Kyoto, Japan.

ORCID-Profile: Yasufumi Matsumura

Förderung

  • COVID-19 Private Fund (to the Shinya Yamanaka laboratory, CiRA, Kytoo, Japan)
  • Nippon Control System
  • Beckman Coulter

Zitieren

APA

Matsumura, Y., Nakazaki, T., Kitamori, K., Kure, E., Shinohara, K., Tsuchido, Y., Yukawa, S., Noguchi, T., Yamamoto, M., & Nagao, M. (2023). Development and evaluation of the automated multipurpose molecular testing system PCRpack for high-throughput SARS-CoV-2 testing. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02716-23

Vancouver

Matsumura Y, Nakazaki T, Kitamori K, Kure E, Shinohara K, Tsuchido Y, et al. Development and evaluation of the automated multipurpose molecular testing system PCRpack for high-throughput SARS-CoV-2 testing. Microbiology Spectrum. 2023. doi:10.1128/spectrum.02716-23

BibTeX
@article{Matsumura2023,
  author = {Matsumura, Yasufumi and Nakazaki, Tomofumi and Kitamori, Kanako and Kure, Eiki and Shinohara, Koh and Tsuchido, Yasuhiro and Yukawa, Satomi and Noguchi, Taro and Yamamoto, Masaki and Nagao, Miki},
  title = {Development and evaluation of the automated multipurpose molecular testing system PCRpack for high-throughput SARS-CoV-2 testing},
  journal = {Microbiology Spectrum},
  year = {2023},
  doi = {10.1128/spectrum.02716-23}
}
Kostenlos starten →